JUAN FRANCISCO
ARENILLAS LARA
CATEDRATICOS DE UNIVERSIDAD
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitari de Girona Dr. Josep Trueta (18)
2023
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
2021
-
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
Neurologia, Vol. 36, Núm. 6, pp. 462-471
-
Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology
Neurologia, Vol. 36, Núm. 4, pp. 305-323
2020
-
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial
Neurological Research and Practice, Vol. 2, Núm. 1
2019
-
Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients
Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164
2017
-
GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke
Stroke, Vol. 48, Núm. 5, pp. 1147-1153
-
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
The Lancet Neurology, Vol. 16, Núm. 5, pp. 369-376
2014
-
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment
Neurologia
-
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial
The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460
2013
-
Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603
2012
-
Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores
Cerebrovascular Diseases, Vol. 33, Núm. 2, pp. 182-189
2011
-
Plan de asistencia sanitaria al ICTUS II. 2010
Neurologia, Vol. 26, Núm. 7, pp. 383-396
2008
-
Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment
Disease Markers, Vol. 25, Núm. 3, pp. 181-188
-
Body temperature and response to thrombolytic therapy in acute ischaemic stroke
European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389
2007
-
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
Stroke, Vol. 38, Núm. 1, pp. 90-95
-
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study
Stroke, Vol. 38, Núm. 6, pp. 1855-1859
-
The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome
Stroke, Vol. 38, Núm. 10, pp. 2759-2764